BBR Partners’s NexImmune, Inc. Common Stock NEXI Stock Holding History

BBR Partners’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-800	Closed	-$7.6K	–	173
2023 Q1	$7.6K	Buy	+800	New	+$8.4K	﹤0.01%	165

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Caprock Group Boise, Idaho $4.12B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBR Partners's NEXI Position: Q2 2023 in Review

BBR Partners sold out of NexImmune, Inc. Common Stock (NEXI) in Q2 2023, closing a stake of 800 shares — an estimated $7.6K sold.

BBR Partners first reported a position in NEXI in Q1 2023 and held it in 1 quarter. The position peaked at $7.6K in Q1 2023. 32 funds tracked by Wall St. Rank hold NEXI as of Q2 2023.

BBR Partners reported no remaining NexImmune, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
BBR Partners sold 800 NexImmune, Inc. Common Stock shares in Q2 2023, an estimated $7.6K.
BBR Partners first reported a position in NexImmune, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
BBR Partners's NexImmune, Inc. Common Stock position peaked at $7.6K in Q1 2023.
32 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q2 2023.

Based on BBR Partners's 13F filing for Q2 2023, filed 8 Aug 2023.